0001807811-21-000003.txt : 20210527 0001807811-21-000003.hdr.sgml : 20210527 20210527104322 ACCESSION NUMBER: 0001807811-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 EFFECTIVENESS DATE: 20210527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Interius BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001807811 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-400861 FILM NUMBER: 21969461 BUSINESS ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE STREET 2: BUILDING 200, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19146 BUSINESS PHONE: 215-608-9333 MAIL ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE STREET 2: BUILDING 200, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19146 D 1 primary_doc.xml X0708 D LIVE 0001807811 Interius BioTherapeutics, Inc. 3401 GRAYS FERRY AVENUE BUILDING 200, SUITE 300 PHILADELPHIA PA PENNSYLVANIA 19146 215-608-9333 DELAWARE None None Corporation true 2019 Philip R. Johnson, M.D. 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Executive Officer Director Dora Mitchell 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Executive Officer Lori Forrest 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Executive Officer Leon Moulder, Jr. c/o Tellus BioVentures, LLC 10831 Isola Bella Court Miromar Lakes FL FLORIDA 33913 Director Benjamin Lund 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Director Tomas Kiselak 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Director Biotechnology Decline to Disclose 06b false 2021-05-14 true true false 0 76344951 43625657 32719294 false 25 0 0 0 false Interius BioTherapeutics, Inc. /s/Philip R. Johnson, M.D. Philip R. Johnson, M.D. President and CEO 2021-05-27